|
ZNF225 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.0555003799625E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34870012327804E-10 |
| Normal-vs-Stage2 |
1.83130000053211E-08 |
| Normal-vs-Stage3 |
2.936650922436E-12 |
| Normal-vs-Stage4 |
3.01814129244349E-12 |
| Stage1-vs-Stage2 |
6.111400E-01 |
| Stage1-vs-Stage3 |
3.052100E-02 |
| Stage1-vs-Stage4 |
1.813920E-02 |
| Stage2-vs-Stage3 |
4.628300E-02 |
| Stage2-vs-Stage4 |
1.695600E-02 |
| Stage3-vs-Stage4 |
4.864800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.76719758218746E-11 |
| Normal-vs-AfricanAmerican |
1.83149999610777E-08 |
| Normal-vs-Asian |
9.42350000254777E-08 |
| Caucasian-vs-AfricanAmerican |
9.774400E-01 |
| Caucasian-vs-Asian |
1.267570E-01 |
| AfricanAmerican-vs-Asian |
3.259000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3106005170016E-10 |
| Normal-vs-Female |
3.56770168963294E-11 |
| Male-vs-Female |
7.309800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.98060514842314E-11 |
| Normal-vs-Age(41-60Yrs) |
1.10540021580618E-10 |
| Normal-vs-Age(61-80Yrs) |
1.25129906436428E-11 |
| Normal-vs-Age(81-100Yrs) |
2.182500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.202000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.854800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.786600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.518200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.584400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.072800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.37929999999942E-05 |
| Classical-VS-Follicular |
3.482600E-01 |
| Classical-VS-Other |
4.464600E-01 |
| Classical-VS-Normal |
1.00120001178539E-09 |
| Tall-VS-Follicular |
3.944800E-03 |
| Tall-VS-Other |
2.674400E-01 |
| Tall-VS-Normal |
1.72806213782906E-12 |
| Follicular-VS-Other |
6.717600E-01 |
| Follicular-VS-Normal |
4.31349955754001E-10 |
| Other-VS-Normal |
1.976810E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85059967350298E-10 |
| Normal-vs-N1 |
1.164002227938E-11 |
| N0-vs-N1 |
1.331980E-01 |
|
|
